Free Standard Shipping on order $250+and +10% with Bank Pay
1 / 6
GLP Peptides · Popular Peptides
Mazdutide Peptide
$128.00
99% Pure | Multi Dose | Finished in the USA
Mazdutide peptide is an emerging dual GLP-1/GCG receptor agonist peptide under investigation for incretin and glucagon receptor signalling, glucose metabolism, and insulin sensitivity. As part of the next generation of metabolic-focused peptides, Mazdutide is studied for its synergistic activation of glucagon and GLP-1 receptors, which are examined in lipid-oxidation and energy-expenditure pathway research.
For Research Use Only. Not for human consumption or therapeutic treatment.
99% Pure | Multi Dose | Finished in the USA
Mazdutide peptide is an emerging dual GLP-1/GCG receptor agonist peptide under investigation for incretin and glucagon receptor signalling, glucose metabolism, and insulin sensitivity. As part of the next generation of metabolic-focused peptides, Mazdutide is studied for its synergistic activation of glucagon and GLP-1 receptors, which are examined in lipid-oxidation and energy-expenditure pathway research. Commonly referred to as a “next-gen GLP-1 analog,” Mazdutide peptide is quickly gaining attention in the research community—especially in models studying obesity, type 2 diabetes, and metabolic syndrome in men.
What Is the Mazdutide Peptide?
Mazdutide is a long-acting synthetic peptide designed to simultaneously stimulate GLP-1 and glucagon receptors. By influencing both appetite and energy expenditure mechanisms, Mazdutide is under evaluation for its potential to address obesity and metabolic disorders. Unlike single-receptor GLP-1 analogs, Mazdutide engages a second signalling pathway alongside GLP-1. In current research, Mazdutide for men has shown particular promise in improving lean mass retention, glucose metabolism, and fat oxidation—making it a key candidate in body composition and metabolic performance studies.
Why Choose Mazdutide Peptide?
Mazdutide peptide goes beyond typical GLP-1 analogs. Its dual-receptor activity opens up broader pathways for metabolic modulation. Where GLP-1 receptor agonists curb appetite and improve insulin sensitivity, Mazdutide also activates glucagon receptors, which play a role in fat oxidation and increasing energy output. This combined action is studied for its effect on body-weight, lipid and glucose regulation in research settings.
With long-acting pharmacokinetics, Mazdutide allows for extended receptor activation, making it suitable for models exploring chronic metabolic conditions or metabolic adaptation.
Why Choose Mazdutide?
Researchers choose Mazdutide peptide because of its dual-receptor design and unique metabolic potential. By stimulating both GLP-1 and glucagon receptors, Mazdutide offers a distinct receptor profile for metabolic and energy-regulation research than traditional GLP-1 agonists. This makes it especially relevant for research focused on fat oxidation, appetite suppression, and glucose homeostasis. At Real Peptides, Mazdutide is manufactured in Finished in the USA, batch-tested for ≥99% purity, and shipped cold to maintain research integrity. Whether your focus is metabolic adaptation or insulin signalling, Mazdutide from Real Peptides provides a reliable foundation for high-quality, compliant research.
Research observations
01
Dual Agonist Activity (GLP-1 & Glucagon)
Activates two key receptors that modulate appetite suppression and caloric expenditure.
02
Body Weight Reduction in Models
Studied for significant reductions in body weight and visceral fat in preclinical subjects.
03
Improved Glucose Control
Promotes insulin sensitivity and glycemic stability without spiking insulin.
04
Appetite Suppression
Reduces food intake in rodent models, with longer satiety windows.
05
Fat Oxidation & Energy Expenditure
Glucagon receptor activation supports lipolysis and thermogenesis.
06
Potential Synergy with Other Peptides
May complement protocols involving MOTS-c, Tesofensine, or Cagrilintidein research models examining metabolic and energy-regulation pathways.
Tested 16-Jun-2026
Kovera · 2 reports
1 earlier
CompoundMazdutide Peptide
Research areaGLP Peptides, Popular Peptides, Metabolic Peptides, Mitochondrial & Metabolic Pathway Research
FormatLyophilised powder, sealed glass vial
Sizes12mg
Reconstituted shelf life30 days at 2–8°C
Independent laboratoryFreedom Diagnostics and Kovera
Lab reports on file2 reports
Ships fromSaint Petersburg, FL and California
DispatchWithin 24 hours
Published research examines Mazdutide in the context of incretin and glucagon receptor signalling, glucose metabolism, insulin sensitivity, and energy regulation in preclinical models.
Mazdutide also activates the glucagon receptor, offering potential effects on lipolysis and thermogenesis in addition to appetite suppression.
Yes, several preclinical and early-phase clinical studies have explored Mazdutide for men, particularly for its impact on body composition and glucose regulation.
Researchers often pair Mazdutide with peptides like Tesofensine, Cagrilintide, or MOTS-cto investigate synergy in metabolic-pathway research designs.
While Tirzepatide targets GLP-1 and GIP receptors, Mazdutide targets GLP-1 and glucagon, offering a different receptor profile for lipid-oxidation and energy-expenditure research.
It’s supplied in a lyophilized multi-dose vial, intended for reconstitution with BAC water and for laboratory use only.
It simultaneously stimulates GLP-1R and GCGR, which may result in decreased appetite, increased thermogenesis, and improved glucose metabolism.
All Real Peptides products are tested at ≥99% purity, and shipped cold with integrity guarantees.
Its long-acting structure supports weekly administration protocols in long-term metabolic research.
Yes, Mazdutide is available for laboratory research purposes only and is not approved for human consumption.
1 / 6
